济川药业4月19日公告,公司2024年一季度营业收入24.03亿元,同比增长0.6%;归母净利润8.45亿元,同比增长24.9%;基本每股收益0.923元。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.